Surgical Outcomes of Mitomycin C Augmented Trabeculectomy in Congenital Glaucoma
Doi: 10.36351/pjo.v41i4.2113
DOI:
https://doi.org/10.36351/pjo.v41i4.2113Abstract
Purpose: To evaluate outcomes of augmented trabeculectomy in lowering IOP in eyes with Congenital Glaucoma and to report the post-operative complications.
Study Design: Retrospective chart review.
Place and Duration of Study: Al-Shifa Trust Eye Hospital, Rawalpindi from July 2022 and April 2024.
Methods: This study evaluated the outcomes of Mitomycin C-augmented trabeculectomy in 78 children (102 eyes) under 3 years of age with primary or secondary congenital glaucoma. All patients were followed for one-year post-surgery. Intraocular pressure (IOP) was measured under sedation using a hand-held Perkins applanation tonometer at various intervals up to 12 months. Surgical success was defined as achieving an IOP of ≤19 mm Hg, categorized into absolute success (without medications) and qualified success (with medications). Failure was defined as uncontrolled IOP despite topical therapy. Data were analyzed using SPSS version 23.
Results: Of the included eyes, 59.8% had primary congenital glaucoma (PCG) and 40.2% had secondary congenital glaucoma (SCG). The mean age was 18.24 ± 9.22 months, and 41% were boys. The mean IOP at 12 months was significantly reduced compared to baseline, with no significant difference between PCG and SCG groups (p=0.76). Postoperative complications were minimal; only 11.76% required further intervention, mostly anterior chamber reformation. One case each of retinal detachment and bleb leak was successfully managed.
Conclusion: Mitomycin C-augmented trabeculectomy is a safe and effective procedure for both PCG and SCG, with comparable success rates between the two groups at one year.

Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Najia Uzair, Sumaira Altaf, Sarah Naveed Malik, Rabeeah Zafar, Shafaq Najmi

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.